Lv1
20 积分 2025-06-04 加入
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
11小时前
待确认
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity
11小时前
已完结
TH2 cell development and function
3天前
已完结
Signaling mechanisms, interaction partners, and target genes of STAT6
3天前
已完结
Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology
4天前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
Functional capacity in a rat model of heart failure: impact of myocardial infarct size
11天前
已完结
Evolving Strategies for the Management of Obstructive Hypertrophic Cardiomyopathy
11天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
12天前
已完结
Protein degraders push into novel target space
12天前
已完结
皖公网安备34019202002308
